SELLAS Life Sciences (SLS) Dividends Paid - Common (2018)
SELLAS Life Sciences (SLS) posted quarterly Dividends Paid - Common of $376000.0 for Q3 2018.
SELLAS Life Sciences (SLS) Dividends Paid - Common (2018) Analysis & Trends
SELLAS Life Sciences (SLS) has reported Dividends Paid - Common for 1 consecutive years, with $376000.0 the latest figure, recorded in Q3 2018.
- In Q3 2018, Dividends Paid - Common changed N/A year-over-year to $376000.0; the TTM figure through Dec 2019 stood at $376000.0 (changed 0.0% YoY), while the FY2018 annual figure was $487000.0, changed N/A from the prior year.
- Dividends Paid - Common held at $376000.0 in Q3 2018 per SLS's latest filing.
- Across five years, Dividends Paid - Common topped out at $376000.0 in Q3 2018 and bottomed at $376000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 34.60 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | SELLAS Life Sciences | 2.32 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 376,000.00 |
| Sep 30, 2018 | 376,000.00 |